CTLA4 Antikörper (N-Term)
Kurzübersicht für CTLA4 Antikörper (N-Term) (ABIN2138472)
Target
Alle CTLA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- CTLA4 antibody was purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- CTLA4 antibody (N terminal) was raised in Rabbit using a KLH conjugated synthetic peptide between 57-86 amino acids from the N-terminal region of human IDDM12 as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- ELISA: 1:1000, IHC: 1:1:50-100, WB: 1:100-500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid In PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Andere Bezeichnung
- CTLA4
-
Pathways
- Cancer Immune Checkpoints
Target
-